Skip to main content
. 2018 Dec 13;10(4):274. doi: 10.3390/pharmaceutics10040274

Figure 2.

Figure 2

Effect of CRY on the viability of HepG2 and MDA-MB-468 cells. ** p < 0.01 and *** p < 0.001 (analysis of variance (ANOVA) + multiple Dunnett’s comparison post-test); denotes a statistically significant reduction of cell viability compared to control (i.e., vehicle-treated cells). A cell viability lower than 70% respect to control was considered as cytotoxic [26].